Search company, investor...
Industrial Microbes company logo

Industrial Microbes

imicrobes.com

Founded Year

2014

Stage

Incubator/Accelerator | Alive

Total Raised

$120K

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+80 points in the past 30 days

About Industrial Microbes

Industrial Microbes invents green manufacturing methods using synthetic biology to bring chemical products to market. The company's platform uses microorganisms to convert methane and carbon dioxide into building-block chemicals that are used in fuels and biodegradable plastics. It was founded in 2014 and is based in Emeryville, California.

Headquarters Location

1250 45th Street Suite 330

Emeryville, California, 94608,

United States

Missing: Industrial Microbes's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Industrial Microbes's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Industrial Microbes

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Industrial Microbes is included in 2 Expert Collections, including Synthetic Biology.

S

Synthetic Biology

305 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.

R

Renewable Energy

2,914 items

Includes companies working on technology to support renewable energy generation.

Industrial Microbes Patents

Industrial Microbes has filed 7 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Beijerinckiaceae
  • Integral membrane proteins
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/17/2016

1/19/2021

Alkanes, Molecular biology, Biotechnology, G protein coupled receptors, Ion channels

Grant

Application Date

11/17/2016

Grant Date

1/19/2021

Title

Related Topics

Alkanes, Molecular biology, Biotechnology, G protein coupled receptors, Ion channels

Status

Grant

Latest Industrial Microbes News

Sam Altman: The Quick, Deep Thinker Leading OpenAI

May 16, 2023

OpenAI chief Sam Altman reasons that combining robotics, artificial intelligence and cheap energy such as fusion could allow machines to essentially do the work and people to reap the benefitsAFP An influential Silicon Valley presence for more than a decade, OpenAI CEO Sam Altman is emerging as the tech titan of the AI age, riding the wave of ChatGPT, the bot his company unleashed on the world. Altman testified Tuesday to a US Senate Judiciary Committee panel and said artificial intelligence could be at a "printing press" moment, which would make him one of its main pioneers. In 2015, Altman joined Tesla chief Elon Musk and others in starting OpenAI, a research company with a stated goal of building generative AI that benefits humanity. "The technological progress we make in the next 100 years will be far larger than all we've made since we first controlled fire and invented the wheel," Altman said in a 2021 blog post. Born in 1985 into a Jewish family, Altman grew up in a St. Louis suburb, where he got his first computer at the age of eight, according to a long profile in the New Yorker from 2016. Computers and the access to online community they enable helped him navigate being gay in a conservative part of the country, Altman said in an interview with Esquire. Like so many tech figures before him, Altman dropped out of Stanford University to start a company, Loopt, which let smartphone users selectively share their whereabouts. Loopt was acquired in 2012 in a deal valued at $43.4 million -- and Altman's place in Silicon Valley was secured. Altman took a year off during which he "read many dozens of textbooks; I learned about the fields that I had been interested in," the San Francisco resident wrote in a post. He told of learning about nuclear engineering, synthetic biology, investing, and AI. "The seeds were planted for things that worked in deep ways later," he said. In 2014, Altman became president of Y Combinator, an "accelerator" that provides startups with guidance and funding in exchange for stakes in the young companies. Altman expanded Y Combinator's strategy for investing beyond software startups to biotech, energy, and other fields. "He thinks quickly and talks quickly; intense, but in a good way," said Industrial Microbes founder Derek Greenfield, who met Altman while his biotech startup was getting backing from Y Combinator. Greenfield recalled Altman always dressing casually, sometimes in a T-shirt and shorts. "He was very down to earth," Greenfield said. Altman left Y Combinator, putting his energy into artificial intelligence despite feared risks. "He's a very deep thinker who is incredibly focused on getting things right," Insider Intelligence senior director of marketing and commerce Jeremy Goldman said. Altman backed a "United Slate" political project in 2018 aimed at improving housing and healthcare policy. He also held a fundraising event for 2020 US presidential candidate Andrew Yang, who advocated for universal basic income. Yang "had some ideas about universal basic income that (he said) everybody needed, in part because AI was going to take the people's jobs," Goldman said. Altman has proposed that combining artificial intelligence, robotics, and cost-free energy could essentially enable machines to do all the work and provide a "basic income" to adults across society. "A great future isn't complicated: we need technology to create more wealth, and policy to fairly distribute it," Altman wrote in a blog post. "Everything necessary will be cheap, and everyone will have enough money to be able to afford it." In the New Yorker article, Altman said he was a "prepper," someone who has preparations and supplies in place to survive an apocalyptic disaster. He has spoken of owning high-performance sports cars and renting planes to fly around California. Altman said in a blog post that the last day of each December he writes a list of things he wants to accomplish in the year ahead. His personal investments include startups working on fusion energy and human life extension. "I'm super optimistic," he said in a podcast with TED curator Chris Anderson. "It's always easy to doom scroll and think about how bad things are," Altman added, "but the good things are really good and getting much better." Influential artificial intelligence pioneer Sam Altman, seen here testifying before the US Senate on May 16, 2023, is 'intense, but in a good way,' says Industrial Microbes founder Derek GreenfieldAFP © Copyright AFP 2023. All rights reserved. IBT Fast Start - Let the best of International News come to you Sign up and stay up to date with our daily newsletter. You can unsubscribe at any time. By signing up you are agreeing to our Terms of Service and Privacy Policy . Join the Discussion

Industrial Microbes Frequently Asked Questions (FAQ)

  • When was Industrial Microbes founded?

    Industrial Microbes was founded in 2014.

  • Where is Industrial Microbes's headquarters?

    Industrial Microbes's headquarters is located at 1250 45th Street, Emeryville.

  • What is Industrial Microbes's latest funding round?

    Industrial Microbes's latest funding round is Incubator/Accelerator.

  • How much did Industrial Microbes raise?

    Industrial Microbes raised a total of $120K.

  • Who are the investors of Industrial Microbes?

    Investors of Industrial Microbes include Plug and Play Accelerator and Y Combinator.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.